These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Glycoside therapy in coronary disease]. Dietmann K. Wien Med Wochenschr; 1977 Oct 30; 127(20):627-30. PubMed ID: 144371 [No Abstract] [Full Text] [Related]
45. [Comparative evaluation of long-acting nitro preparations in patients with ischemic heart disease and stable angina pectoris of different functional classes]. Zhebel' VN, Mikunis RI. Klin Med (Mosk); 1995 Oct 30; 73(5):74. PubMed ID: 8815293 [No Abstract] [Full Text] [Related]
47. [Use of nitrong in patients with ischemic heart disease]. Serova IV, Kuleshova NN. Kardiologiia; 1982 Aug 30; 22(8):115. PubMed ID: 6813554 [No Abstract] [Full Text] [Related]
54. [Topic application of nitroglycerin in prophylaxis and therapy of angina pectoris]. Vorberg G. Fortschr Med; 1978 Dec 07; 96(46):2344-6. PubMed ID: 102575 [No Abstract] [Full Text] [Related]
56. The effect of antianginal drugs on myocardial oxygen consumption. Fuller EO. Am J Nurs; 1980 Feb 07; 80(2):250-4. PubMed ID: 6766665 [No Abstract] [Full Text] [Related]
57. The mechanism of action of nitroglycerin. Stenosis vasodilation as a major component of the drug response. Dodge HT, Brown BG. Scand J Clin Lab Invest Suppl; 1984 Feb 07; 173():41-5. PubMed ID: 6442001 [No Abstract] [Full Text] [Related]
60. [Anti-angina treatment in stable forms of angina pectoris with emphasis on nitrates]. Murín J. Vnitr Lek; 1999 Feb 07; 45(2):122-6. PubMed ID: 15641233 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]